CLINICAL RESEARCH IN ASIA PACIFIC
WHY ASIA PACIFIC?
ASIA PACIFIC, RAPID GROWTH
Economic growth remains strong in Asia Pacific markets. The Asia Pacific drug development market is projected to expand ... see more
GOOD CLINICAL INFRASTRUCTURE
There is continuous growth in the scientific base and capabilities in Asia, encouraged by local authorities ...see more
EFFICIENT REGULATORY AND ETHICS COMMITEE PROCESSES
With the appropriate approach, the regulatory approval processes in most Asia is no more complex than in the US or Europe ...see more
ICH GCP AS THE ONLY STANDARD
Most APAC countries adhere to ICH GCP in their processes for EC committee submission and regulatory approval ...see more
FASTER PATIENT RECRUITMENT AND HIGH RETENTION
Asia offers a large and diverse patient pool, with nearly 60% of the world population living in the region ...see more
COST BENEFITS
Including investigator sites in Asia can help reduce the overall drug development timelines ...see more
IP AND LEGAL
IP protection in Asia remains an issue when compared to Western standards. However, there has been significant progress ...see more
LOGISTICS
There are strict customs regulations within each country to comply with. Strategies to deal with ...see more